erenumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
AIMOVIG erenumab (rch) 70 mg/mL solution for injection in pre-filled pen AUST R: 289959Active ingredients:
erenumab
Dosage form:
Injection, solution
Sponsor:
Novartis Pharmaceuticals Australia Pty Ltd
Phone:
029803555
|
From
10 Dec 2025
to
15 Jan 2026
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
An alternative strength is available.
|